Embed

Academic

Authors

Brigitte Guckel

Brigitte Guckel (Brigitte Gückel),University of Tübingen,Oncology,Ophthalmology,Immunology

Edit

Brigitte Guckel (Brigitte Gückel)

University of Tübingen

Publications: 27 | Citations: 122

Fields: Oncology, Ophthalmology, Immunology

Collaborated with 685 co-authors from 1991 to 2011 | Cited by 544 authors

Cumulative Annual

Sort by:

Publications (27)

BibTeX | RIS | RefWorks Download

Simvastatin reduces tumor cell adhesion to human peritoneal mesothelial cells by decreased expression of VCAM-1 and beta1 integrin

, , , , , , , , ,

Journal: International Journal of Oncology - INT J ONCOL , pp. 1593-1600, 2011

Peptide microarrays for the profiling of cytotoxic T-lymphocyte activity using minimum numbers of cells

, , , , , ,

Journal: Cancer Immunology Immunotherapy - CANCER IMMUNOL IMMUNOTHER , vol. 59, no. 9, pp. 1379-1387, 2010

Zelluläre Immuntherapie: Ein neuer Ansatz in der Therapie des Mammakarzinoms

Journal: Geburtshilfe Und Frauenheilkunde - GEBURTSH FRAUENHEILK , vol. 67, no. 4, pp. 370-375, 2007

Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers (Citations: 5)

, , , , , , ,

Journal: Journal of Cancer Research and Clinical Oncology - J CANCER RES CLIN ONCOL , vol. 132, no. 4, pp. 265-274, 2006

Vaccination in the therapy of breast cancer

Journal: Onkologe , vol. 12, no. 3, pp. 253-262, 2006

Sort by:

Citations (122 times by 109 publications)

Adoptive Therapy Using Antigen-Specific T-Cell Clones (Citations: 2)

Journal: Cancer Journal - CANCER J , vol. 16, no. 4, pp. 367-373, 2010

Phase-I clinical trial of IL12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer (Citations: 1)

, , , ,

Journal: Gene Therapy , vol. 17, no. 3, pp. 360-369, 2010

NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer (Citations: 1)

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=33830195&selfId1=24606381&selfId2=0&maxNumber=12&query=

Journal: International Journal of Cancer - INT J CANCER , pp. NA-NA, 2010

Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease A Phase II Study of BTI-322, a Monoclonal Anti-CD2 Antibody, for

, , , , , , , , ,

Published in 2010.

Employing a CD2Based Strategy Triggering Steps Can Be Separated Antibody: The Targeting and Tumor Therapy with Bispecific

, , , ,

Published in 2010.

Comments

Co-authors (685)

Journals (14)

Keywords (77)

Brigitte Guckel (Brigitte Gückel),University of Tübingen,Oncology,Ophthalmology,Immunology

Publications (27)

BibTeX | RIS | RefWorks Download

Simvastatin reduces tumor cell adhesion to human peritoneal mesothelial cells by decreased expression of VCAM-1 and beta1 integrin

Peptide microarrays for the profiling of cytotoxic T-lymphocyte activity using minimum numbers of cells

Zelluläre Immuntherapie: Ein neuer Ansatz in der Therapie des Mammakarzinoms

Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers (Citations: 5)

Vaccination in the therapy of breast cancer

Citations (122 times by 109 publications)

Adoptive Therapy Using Antigen-Specific T-Cell Clones (Citations: 2)

Phase-I clinical trial of IL12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer (Citations: 1)

NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer (Citations: 1)

Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease A Phase II Study of BTI-322, a Monoclonal Anti-CD2 Antibody, for

Employing a CD2Based Strategy Triggering Steps Can Be Separated Antibody: The Targeting and Tumor Therapy with Bispecific


	View FAQ about top research areas and Fields of study

Brigitte Guckel (Brigitte Gückel),University of Tübingen,Oncology,Ophthalmology,Immunology

Publications (27) BibTeX | RIS | RefWorks Download

Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers (Citations: 5)

Adoptive Therapy Using Antigen-Specific T-Cell Clones (Citations: 2)

Phase-I clinical trial of IL12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer (Citations: 1)

NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer (Citations: 1)

Publications (27)

BibTeX | RIS | RefWorks Download